Previous 10 | Next 10 |
Medpace Holdings, Inc. (MEDP) Q4 2022 Earnings Conference Call February 14, 2023, 09:00 AM ET Company Participants Lauren Morris - IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants Sandy Draper - Guggenheim...
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Medpace Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation
Medpace press release ( NASDAQ: MEDP ): Q4 GAAP EPS of $2.12 beats by $0.33 . Revenue of $394.1M (+27.7% Y/Y) beats by $8.01M . EBITDA was $80.4 million for the fourth quarter of 2022, an increase of 30.9% from EBITDA of $61.4 million for the comparable prior-year peri...
Revenue of $394.1 million in the fourth quarter of 2022 increased 27.7% from revenue of $308.6 million for the comparable prior-year period, representing a backlog conversion rate of 17.6%. Net new business awards were $485.1 million in the fourth quarter of 2022, representing an increase...
Summary Vulcan Value Partners are value investors - business analysts with a long-term time horizon focused on purchasing publicly traded companies that are competitively entrenched at significant discounts to intrinsic worth. After a difficult first nine months of the year, all five of...
Summary Heading into its FY22 earnings in February, Medpace Holdings' share price has caught another bid. With that in mind, we wanted to examine investor positioning leading into MEDP's full-year numbers. Investors have positioned with a bullish tilt which creates an asymmetrical r...
Medpace Holdings (NASDAQ: MEDP) and Doximity (NYSE: DOCS) hold unique spots in the healthcare industry, with Medpace being a Top-10 clinical contract research organization (CRO) and Doximity being the best way for advertisers to reach physicians. Both companies have sound fi...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023. The Company will host a conference call the following morning, Tuesday, February 14, 2...
Summary Vulcan Value Partners are value investors - business analysts with a long-term time horizon focused on purchasing publicly traded companies that are competitively entrenched at significant discounts to intrinsic worth. All five strategies trailed their respective benchmark...
While stocks that go hyperbolic in a bull market may garner more attention during their climb phase, companies that are capable of thriving in turbulent markets may be more valuable to investors over the long term. That second type of resilience is a critical attribute that Nasdaq-liste...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...